Efficacy and safety of olezarsen in lowering apolipoprotein C-III and triglycerides in healthy Japanese Americans
Abstract Background Olezarsen is a GalNAc3-conjugated, hepatic-targeted antisense oligonucleotide that lowers apolipoprotein C-III (apoC-III) and triglyceride levels. The efficacy and safety of olezarsen has not previously been studied in ethnically diverse American populations. The aim of this stud...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2024-10-01
|
| Schriftenreihe: | Lipids in Health and Disease |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s12944-024-02297-5 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
